Bell Graeme 4
4 · Intellia Therapeutics, Inc. · Filed Mar 30, 2018
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-03-28$13.48/sh+8,000$107,840→ 21,400 total - Exercise/Conversion
Stock Option (Right to buy)
2018-03-28−8,000→ 202,000 totalExercise: $13.48Exp: 2027-01-02→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]On January 3, 2017, the Reporting Person was granted an option to purchase 210,000 common shares under the company's 2015 Amended and Restated Stock Option and Incentive Plan. The shares reported as being purchased in this Form 4 were fully vested and exercisable as of the transaction date.